Search NLS News

Unfortunately genes do matter when it comes to obesity, but knowledge about these genes and how they work are key to improving treatment and prevention. “Over the past two decades, genetic association studies have identified hundreds of genetic variations that affect body weight. Individuals who inherit many of these variations are more susceptible to gaining […]

This strategic investment unlocks new product offerings for Genovis to both existing and new customers and further paves the way for the expansion into new application areas, it states. Following the investment, Genovis will own 25 percent of Sequrna. As part of the transaction, the parties have agreed to a call option with an end […]

The research funding of EUR 3.6 million will finance Herantis’ Phase 1b clinical trial and expand the on-going biomarker project, it states. “We are proud to be awarded funding for the HER-096 Phase 1b clinical trial from Parkinson’s Virtual Biotech and The Michael J. Fox Foundation, two prestigious organizations in this field. This external validation […]

AddLife acquires BonsaiLab, a Spanish distributor in the field of cell and molecular biology. The company, with current revenues of EUR 8 million, has operations in Spain and Portugal and will be included in AddLife’s business area Labtech. BonsaiLab will be included in the Biomedical and Research business unit, a part of the Labtech business […]

Medivir has presented new data from its ongoing phase Ib/IIa study of fostroxacitabine bralpamide (fostrox) + Lenvima in advanced hepatocellular carcinoma (HCC) at the European Society of Medical Oncology, Gastrointestinal Cancers Cancers Congress in Munich, Germany. The data shows an overall response rate (ORR) of 24%, with a disease control rate (DCR) of 81%, while […]

Alligator Bioscience has announced positive 18-month follow-up data from the OPTIMIZE-1 Phase 2 study of the company’s lead asset mitazalimab in 1st line metastatic pancreatic cancer. The open-label, multi-center study assessed the safety and efficacy of mitazalimab (CD40 mAb agonist) in combination with standard of care chemotherapy mFOLFIRINOX, in previously untreated, chemotherapy naïve pancreatic cancer […]

Simsen Diagnostics is announcing a new collaboration with Orion Corporation during a First-in-Human Phase I study to evaluate Orion’s drug candidate, ODM-212. The primary objective of this Phase I study is dose escalation to determine the optimal dosing regimen for ODM-212. The trial will include a heterogeneous patient population with various types of advanced solid […]

Genmab has announced that the EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of conditional marketing authorization of epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, as a monotherapy for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) after two or […]

Challenges and Funding Dilemmas from an International and Nordic Perspective. It is no secret that obesity is one of the biggest public health challenges of the 21st century and is one of the leading causes of preventable death globally. It’s estimated that 18% of the global population is obese, with the prevalence of obesity in […]

Center for Translational Research (CTR) expands by acquiring Zelmic, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal pharmaceutical formulations and drug delivery. The acquisition further expands CTRs portfolio, within pharmaceutical, regulatory, and clinical development to the CTR group, the company states. “The addition […]